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Dr Joseph D. Schmoker (Burlington, Vt). Congratulations on
your outstanding results.
Both the mortality rate of 2.4% and the stroke rate of 1.6% in
this large series of patients over the span of 11 years is highly
commendable. You have improved on your previous stroke rate
of 3.1% reported in 2007. These results helped to reinforce a
role for DHCA when performed properly in the treatment of
noncomplex aortic arch pathology when the circulatory arrest
times are<40 minutes, such as was the case in your series and
inclusive of almost 90% of your patients.
However, the data interpretation becomes more problematic
when analyzing the risk of stroke with longer arrest times. In
your previous series, the stroke rate was 13% if the arrest
time was >40 minutes. In the present study, the mean arrest
time for those patients with stroke was 39 minutes, and the
stroke rate increased to 17% when the arrest time was
>50 minutes. From these aggregate data, evidence exists of a
strong trend toward an increased stroke risk after 40 minutes
with DHCA alone.
I take issue with your interpretation that your embolic strokes
had no association with the circulatory arrest duration. Emboli
superimposed on cold ischemia can add insult to the vulnerable
at-risk tissue, the penumbra, and certainly could contribute to a
more profound deficit. In that fashion, the circulatory arrest time
could have an effect on stroke severity related to emboli.
This brings me to 3 questions, and we will take each
individually. The definition of stroke used in this project (ie, the
requirement for both a clinical deficit and positive imaging study
findings) might serve to underreport the incidence if careful
imaging was not performed in all patients with a deficit, which
would include those with seizures and other more prolonged
temporary neurologic dysfunction.ery c September 2014
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permanent deficit alone, whether a focal deficit or a generalized
deficit such as a gait disturbance or Parkinsonism, or any deficit,
however, brief or extended associated with a positive finding on
imaging.
Did you follow this definition, and, if so, did all patients with
extended temporary neurologic dysfunction or seizures undergo
appropriate imaging?
Dr Ziganshin. Thank you very much for your comments and
questions, Dr Schmoker.
In terms of the first question, we used the following definition of
stroke: a clinically and radiologically (computed tomography [CT]
or magnetic resonance imaging) recognized neurologic deficit. All
patients with a persisting deficit underwent CT, and, if the deficit
persisted and the CT findings were negative, they underwent
magnetic resonance imaging.
In terms of temporary and neurologic deficits—we found these
very difficult to classify and detect because, in our experience,
most patients who could potentially be considered as having
temporary neurologic deficits had confusion as their postoperative
complication.
Confusion, as we know, can occur not only after procedures
involving DHCA, but also any other procedures requiring
cardiopulmonary bypass.
If the neurologic deficits persisted in these patients, they
subsequently underwent imaging studies. However, in our study,
all patients classified as not having a stroke were discharged
home without any neurologic deficits whatsoever.
Dr Schmoker. Thank you. You also answered my second
question regarding the insensitivity of CT for embolic or ischemic
stroke early after surgery and the need for follow-up with magnetic
resonance imaging.
My last question pertains to a concern about peripheral
cannulation and retrograde perfusion in patients with risk
factors for atheroma; 80% of your patients were perfused from
the groin. Although you engaged more central perfusion if
evidence was found of atheroma in the descending thoracic aorta
on imaging, it appears that no policy was in place to obtain
abdominal imaging preoperatively. It is possible that the embolic
strokes could have occurred from undetected debris dislodged
from the atheromatous abdominal or iliofemoral systems by
retrograde perfusion.
Knowing that 5 patients had embolic stroke and 3 patients had
hypoperfusion as their stroke etiology, what was the breakdown
between the central and peripheral cannulation in these 2 groups?
Thank you.
Dr Ziganshin. Thank you very much for your question,
Dr Schmoker.
That is a very important point, and we do acknowledge that we
could not safely state that in all patients abdominal imaging was
performed.
However, it is a policy at our institution to perform abdominal
CT imaging for all patients undergoing elective surgery.
Of course, in an emergency setting, it is not possible to obtain a
CT image, and then we have to rely on intraoperative transesopha-
geal echocardiography to detect atheromatous debris.
However, as a second point, in our experience, it is very rare to
have severe atherosclerotic disease in the abdominal aorta and toThe Journal of Thoracic and Cahave absolutely no involvement of the descending aorta. That is
why we believe our approach is safe.
In terms of the breakdown between central and peripheral
cannulation, I have it here on the slide. Ten percent of the patients
in the entire study cohort received right axillary cannulation, 9.4%
received distal arch cannulation, and only 1% received innominate
artery cannulation. All other patients were perfused via the
femoral artery.
In terms of the patients with embolic strokes: the total was 5, 2
had been cannulated via the femoral artery, 2 had undergone distal
arch cannulation, and 1 patient had undergone right axillary
cannulation. Thus, we can see that retrograde flow was only
used in 2 of these patients with embolic stroke.
Dr Schmoker. Thank you.
Dr Joseph S. Coselli (Houston, Tex). Quick question. Did you
have any deaths in your series that were unable to be evaluated
neurologically, and if so, how did you include those in your
analysis?
Dr Ziganshin. We had 1 case of an intraoperative death.
That was a case of an acute type A dissection, and we were unable
to include that patient in our neurologic analysis; however, that
patient was included in the study as an early death.
Dr Scott A. LeMaire (Houston, Tex). The rewarming strategy
can also influence the incidence of neurologic complications.
Would you tell us about your rewarming strategy, particularly
because you used bladder temperatures. What temperature do
you rewarm to? What is the rate of rewarming?
Dr Ziganshin. The rewarming time is usually about 1 hour. We
do not hurry with rewarming. We take as much time as needed,
especially for patients who are obese or overweight. Such cases
require a significant amount of rewarming time. The difference
in temperature of the perfusate is about 10C always, and we
rewarm until about 34C.
Dr LeMaire. Thirty-four, okay. Thank you.
Dr Ourania Preventza (Houston, Tex). Congratulations for
this excellent study. I would like to ask you, what was your
transfusion rate during the aortic arch surgery?
Dr Preventza. All your cases were performed with straight
DHCA. What was your transfusion rate during the aortic arch
surgery?
Dr Ziganshin.We did not look at this parameter specifically in
light of this study, but from our clinical experience, the transfusion
rate for our aortic interventions was no different than that for any
other cardiac procedures performed at our center.
The re-exploration rate for bleeding was 4.5%.
Dr Preventza. Okay. Thank you.
Dr Burkhart Zipfel (Berlin, Germany). I have a question on
your double artery island technique.
Dr Zipfel. How do you handle the left subclavian artery then,
do you just occlude it?
Dr Ziganshin. The technique illustrated on the slide is the
preferred technique that we use at our institution. The elephant
trunk graft is usually placed, and we leave it relatively long
if we anticipate a second-stage procedure. If a second-stage
procedure is needed, that means that the descending aorta is
relatively dilated, and there is enough room for retrograde flow
to the left subclavian artery. In our experience, we have not seen
complications related to the left subclavian artery.rdiovascular Surgery c Volume 148, Number 3 899
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procedure to determine whether the flow to the left subclavian
artery is compromised. Because the left subclavian artery has a
radial catheter in it, we check to see whether the central pressure900 The Journal of Thoracic and Cardiovascular Surgis different from the pressure in the radial artery. If it is, we perform
a bypass during the first-stage procedure. If it is not, we leave the
left subclavian artery and manage it during the second-stage
procedure, when this is much easier and safer to do.ery c September 2014
